DRIO — DarioHealth Corp.

Summary of DarioHealth (DRIO) Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Revenue: $5 million for Q3 2025, down from $5.4 million in Q2 2025 and $7.4 million in Q3 2024.
• Gross Margin: GAAP gross margin at 60%, up from 55% in Q2 2025 and 52% in Q3 2024; non-GAAP gross margin consistently above 80% since early 2024.
• Operating Expenses: Reduced by $3.4 million (21%) year-over-year in Q3; total reduction of $17.2 million (31%) for the first nine months of 2025.
• Cash Position: $31.9 million in cash and equivalents as of September 30, 2025, bolstered by a $17.5 million private placement.
• Client Base: Over 125 clients, with 45 new accounts signed in 2025, surpassing the goal of 40.

2. Strategic Updates and Business Highlights

• DarioHealth emphasizes its unique multi-condition digital health platform, integrating physical, mental, and behavioral care.
• More than 50% of new clients opted for the multi-condition solution, indicating a market shift towards comprehensive care.
• Partnerships with major health plans like UnitedHealthcare and Primera Blue Cross are expected to enhance market reach and client engagement.
• The company is transitioning to a recurring revenue model, focusing on high-margin, predictable revenue streams.
• DarioHealth is also expanding its pharma services, targeting specific therapeutic areas to drive engagement and ROI.

3. Forward Guidance and Outlook

• Targeting $12.4 million in new business for implementation in 2026, with significant contributions expected from the current pipeline.
• Anticipates reaching cash flow breakeven by late 2026 to early 2027.
• Plans to further reduce operating expenses by an additional 10% to 15% over the next 12-15 months.

4. Bad News, Challenges, or Points of Concern

• Revenue decline attributed to the nonrenewal of a significant contract with a national health plan and the transition from milestone-based to recurring revenue in the pharma segment.
• Sequential declines in B2B2C revenue, raising concerns about underlying business stability despite a strong client retention rate of 90%.
• Competitive pressures and market dynamics may impact the uptake of multi-condition offerings, with only 50% of new clients choosing this option compared to 80% in the previous quarter.

5. Notable Q&A Insights

• The rollout with UnitedHealthcare is expected to be significant but specific revenue contributions were not disclosed.
• The company is optimistic about the pacing of new business implementation, with most new accounts launching in Q1 2026.
• Management acknowledged the impact of the previous nonrenewal on current revenue metrics but expressed confidence in the stability and growth potential of their core employer and health plan business.
• Strategic partnerships and a refined go-to-market approach are seen as key drivers for future growth, with a focus on aligning product offerings with client needs and market demands.

Overall, DarioHealth is navigating a transitional phase with a focus on enhancing its recurring revenue model, expanding its client base, and leveraging strategic partnerships, despite facing challenges related to revenue fluctuations and competitive pressures.